SINOVAC BIOTECH LTD (SVA) › Shareholders' EquitySINOVAC BIOTECH LTD (SVA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $56.90M2009: $84.47M2010: $147.76M2011: $145.30M2012: $129.44M2013: $142.94M2014: $140.15M2015: $136.50M2016: $129.67M2017: $177.14M2018: $291.93M2019: $352.19M2020: $1.13B2021: $13.55B2022: $12.24B2023: $11.64B2024: $10.29B2025: $6.40B$6.40B2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.40B-37.9%2024$10.29B-11.6%2023$11.64B-4.9%2022$12.24B-9.7%2021$13.55B+1098.1%2020$1.13B+221.2%2019$352.19M+20.6%2018$291.93M+64.8%2017$177.14M+36.6%2016$129.67M-5.0%2015$136.50M-2.6%2014$140.15M-2.0%2013$142.94M+10.4%2012$129.44M-10.9%2011$145.30M-1.7%2010$147.76M+74.9%2009$84.47M+48.4%2008$56.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share